These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 24503330

  • 1. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.
    Hsiao IT, Weng YH, Lin WY, Hsieh CJ, Wey SP, Yen TC, Kung MP, Lu CS, Lin KJ.
    Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330
    [Abstract] [Full Text] [Related]

  • 2. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
    Huang WS, Chiang YH, Lin JC, Chou YH, Cheng CY, Liu RS.
    J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
    [Abstract] [Full Text] [Related]

  • 3. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.
    Lin SC, Lin KJ, Hsiao IT, Hsieh CJ, Lin WY, Lu CS, Wey SP, Yen TC, Kung MP, Weng YH.
    J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322
    [Abstract] [Full Text] [Related]

  • 4. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.
    Weng YH, Yen TC, Chen MC, Kao PF, Tzen KY, Chen RS, Wey SP, Ting G, Lu CS.
    J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678
    [Abstract] [Full Text] [Related]

  • 5. Optimal scanning time window for 18F-FP-(+)-DTBZ (18F-AV-133) summed uptake measurements.
    Lin KJ, Lin WY, Hsieh CJ, Weng YH, Wey SP, Lu CS, Skovronsky D, Yen TC, Chang CJ, Kung MP, Hsiao IT.
    Nucl Med Biol; 2011 Nov; 38(8):1149-55. PubMed ID: 21831650
    [Abstract] [Full Text] [Related]

  • 6. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.
    Hsiao IT, Weng YH, Hsieh CJ, Lin WY, Wey SP, Kung MP, Yen TC, Lu CS, Lin KJ.
    JAMA Neurol; 2014 Jun; 71(6):758-66. PubMed ID: 24756323
    [Abstract] [Full Text] [Related]

  • 7. A phase 2, open-label, multi-center study to evaluate the efficacy and safety of 99mTc-TRODAT-1 SPECT to detect Parkinson's disease.
    Sun Y, Liu C, Chen Z, Li B, Lv Z, Lou J, Tang J, Wang Y, Zhang G, Liu X.
    Ann Nucl Med; 2020 Jan; 34(1):31-37. PubMed ID: 31646428
    [Abstract] [Full Text] [Related]

  • 8. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.
    Hwang WJ, Yao WJ, Wey SP, Ting G.
    J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637
    [Abstract] [Full Text] [Related]

  • 9. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
    Tzen KY, Lu CS, Yen TC, Wey SP, Ting G.
    J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515
    [Abstract] [Full Text] [Related]

  • 10. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK, Knudsen K, Lillethorup TP, Landau AM, Parbo P, Fedorova T, Audrain H, Bender D, Østergaard K, Brooks DJ, Borghammer P.
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [Abstract] [Full Text] [Related]

  • 11. 99mTc-TRODAT-1 SPECT study in early Parkinson's disease and essential tremor.
    Wang J, Jiang YP, Liu XD, Chen ZP, Yang LQ, Liu CJ, Xiang JD, Su HL.
    Acta Neurol Scand; 2005 Dec; 112(6):380-5. PubMed ID: 16281920
    [Abstract] [Full Text] [Related]

  • 12. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
    Bor-Seng-Shu E, Pedroso JL, Felicio AC, de Andrade DC, Teixeira MJ, Braga-Neto P, Batista IR, Barsottini OG, Borges V, Ferraz HB, Shih MC, Bressan RA, de Andrade LA, Walter U.
    Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
    [Abstract] [Full Text] [Related]

  • 13. Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.
    Lin KJ, Weng YH, Hsieh CJ, Lin WY, Wey SP, Kung MP, Yen TC, Lu CS, Hsiao IT.
    PLoS One; 2013 May; 8(9):e75952. PubMed ID: 24098749
    [Abstract] [Full Text] [Related]

  • 14. Comparative Performance of 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT Imaging in Patients With Parkinson's Disease, Parkinson-Plus Syndrome, and Essential Tremor.
    Sood A, Shukla J, Shree R, Vatsa R, Modi M, Mittal BR.
    Clin Nucl Med; 2021 Feb 01; 46(2):95-102. PubMed ID: 33234920
    [Abstract] [Full Text] [Related]

  • 15. In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133.
    Okamura N, Villemagne VL, Drago J, Pejoska S, Dhamija RK, Mulligan RS, Ellis JR, Ackermann U, O'Keefe G, Jones G, Kung HF, Pontecorvo MJ, Skovronsky D, Rowe CC.
    J Nucl Med; 2010 Feb 01; 51(2):223-8. PubMed ID: 20080893
    [Abstract] [Full Text] [Related]

  • 16. 99mTc-TRODAT-1 imaging of multiple system atrophy.
    Lu CS, Weng YH, Chen MC, Chen RS, Tzen KY, Wey SP, Ting G, Chang HC, Yen TC.
    J Nucl Med; 2004 Jan 01; 45(1):49-55. PubMed ID: 14734673
    [Abstract] [Full Text] [Related]

  • 17. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
    Li DH, Zhang LY, Hu YY, Jiang XF, Zhou HY, Yang Q, Kang WY, Liu J, Chen SD.
    Parkinsonism Relat Disord; 2015 Aug 01; 21(8):923-8. PubMed ID: 26066091
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.
    Huang WS, Lin SZ, Lin JC, Wey SP, Ting G, Liu RS.
    J Nucl Med; 2001 Sep 01; 42(9):1303-8. PubMed ID: 11535717
    [Abstract] [Full Text] [Related]

  • 19. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.
    Geng Y, Shi GH, Jiang Y, Xu LX, Hu XY, Shao YQ.
    J Zhejiang Univ Sci B; 2005 Jan 01; 6(1):22-7. PubMed ID: 15593387
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.